Mergers & Acquisitions

The healthcare industry sees a lot of consolidation between both vendors and healthcare providers this channel tracks mergers and acquisitions between large healthcare systems, community hospitals, private practices, vendors and private equity investors. Health systems have been growing in size substantially in the past decade with mergers with smaller healthcare systems and hospitals. This is largely due to the need to be more efficient amid lower reimbursements and rising costs by building an economy of scale in a larger health system. On the vendor side, mergers have become a common way to reduce research and development costs by purchasing intellectual rights for new technologies, or to purchased companies with new technologies that already have regulatory market clearance. 

PSG growth equity redo

Private equity firm PSG invests $80M in radiology vendor Core Sound Imaging

Its flagship product is the Studycast imaging workflow platform, which CSI billed as “more than a picture archiving and communication system." 

Healthcare salaries and compensation

FTC, DOJ and HHS release report warning of private equity consolidation in healthcare

The agencies said private equity firms are rolling up healthcare sectors through serialized purchases that fly under the radar of regulators, creating an unsustainable level of consolidation. 

Houston Texas

Private equity-backed Capitol Imaging acquires 7 outpatient centers in Gulf Coast

The Metairie, Louisiana-based radiology group is acquiring Houston MRI & Diagnostic Imaging, ballooning its center total to 48 across five states. 

radiology clock alarm turnaround time efficiency

Patients continue facing weekslong delays at Radiology Partners affiliate

Margaret Lukasyk of West Hartford, Conn., posted her concerns about Jefferson Radiology on Facebook and received numerous responses. 

Thumbnail

Radiology solutions provider Collaborative Imaging inks partnership with private equity

WindRose Health Investors is partnering with the management team at radiologist-owned CI, acquiring its technology platform and creating a new company called Civie. 

johnson & johnson branding

Johnson & Johnson buys depression drug and its manufacturer for $15B

The drug Caplyta, owned by Intra-Cellular Therapies, is being used to treat bipolar disorder and schizophrenia. In 2024, it brought in more than $481 million in sales. 

Lantheus

Lantheus to acquire PET agent developer Life Molecular Imaging for up to $750M

LMI is the maker of Neuraceq, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s

Telix Pharmaceuticals

Telix Pharmaceuticals to acquire portfolio of imaging-related assets for up to $185M

Inglewood, California-based biotechnology company ImaginAb is the seller, unloading a pipeline of drug candidates, technology platform and research facility.